British Journal of Dermatology

Cover image for Vol. 169 Issue 4

October 2013

Volume 169, Issue 4

Pages i–i, 729–959

  1. Editor's Choice

    1. Top of page
    2. Editor's Choice
    3. Editorial
    4. Commentary
    5. Review articles
    6. Systematic review
    7. Original articles
    8. Case report
    9. Correspondence
    10. Correspondences
    11. Book review
    12. News and Notices
    1. You have free access to this content
      Editor's Choice (page i)

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12605

  2. Editorial

    1. Top of page
    2. Editor's Choice
    3. Editorial
    4. Commentary
    5. Review articles
    6. Systematic review
    7. Original articles
    8. Case report
    9. Correspondence
    10. Correspondences
    11. Book review
    12. News and Notices
  3. Commentary

    1. Top of page
    2. Editor's Choice
    3. Editorial
    4. Commentary
    5. Review articles
    6. Systematic review
    7. Original articles
    8. Case report
    9. Correspondence
    10. Correspondences
    11. Book review
    12. News and Notices
  4. Review articles

    1. Top of page
    2. Editor's Choice
    3. Editorial
    4. Commentary
    5. Review articles
    6. Systematic review
    7. Original articles
    8. Case report
    9. Correspondence
    10. Correspondences
    11. Book review
    12. News and Notices
    1. Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995–2012 (pages 734–759)

      M.S. Salek, S. Jung, L.A. Brincat-Ruffini, L. MacFarlane, M.S. Lewis-Jones, M.K.A. Basra and A.Y. Finlay

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12437

      What's already known about this topic?

      • The quality of life of children can be impaired by skin disease.
      • The CDLQI is a simple 10-item questionnaire to measure the impact of skin diseases on children's quality of life.
      • The CDLQI is available in two versions, text only and text with cartoons.

      What does this study add?

      • The CDLQI has been used in 102 research studies in 28 countries.
      • There is detailed documentation of 14 skin diseases in which there is major impairment of quality of life in children.
      • Previously scattered validation data have been identified and brought together.
      • The CDLQI has strong validation characteristics including high internal consistency, test-retest reliability and responsiveness to change.
      • Some aspects of validation requiring further study have been identified.
    2. Infants' Dermatitis Quality of Life Index: a decade of experience of validation and clinical application (pages 760–768)

      M.K.A. Basra, V. Gada, S. Ungaro, A.Y. Finlay and S.M. Salek

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12563

      What's already known about this topic?

      • The quality of life of infants may be severely affected by atopic dermatitis.
      • As infants cannot answer questions, proxy methods are needed to measure their life quality.
      • The Infants' Dermatitis Quality of Life Index (IDQoL) has been widely used for such assessment.

      What does this study add?

      • The IDQoL has been used in 46 published studies in 18 countries. This review collates the scattered data about the wide use of the IDQoL in clinical and psychometric studies.
      • Seven studies used the IDQoL in assessment of topical therapy and eight in assessment of other treatment interventions.
      • Test–retest reliability, internal consistency, validity, responsiveness to change and interpretability of the IDQoL have been reported across 31 studies.
    3. Plant extracts for the topical management of psoriasis: a systematic review and meta-analysis (pages 769–782)

      S. Deng, B.H. May, A.L. Zhang, C. Lu and C.C.L. Xue

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12557

      What's already known about this topic?

      • Patients with psoriasis frequently use preparations of plant extracts.
      • Physicians need to be aware of the current evidence for the efficacy and safety of these products.

      What does this study add?

      • There is limited but consistent clinical trial evidence for the efficacy of extracts of Mahonia aquifolium and indigo naturalis in plaque psoriasis when compared with the vehicle creams.
      • The magnitude and duration of the effects are not assessable based on currently available data.
  5. Systematic review

    1. Top of page
    2. Editor's Choice
    3. Editorial
    4. Commentary
    5. Review articles
    6. Systematic review
    7. Original articles
    8. Case report
    9. Correspondence
    10. Correspondences
    11. Book review
    12. News and Notices
    1. Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis (pages 783–793)

      P. Coto-Segura, N. Eiris-Salvado, L. González-Lara, R. Queiro-Silva, P. Martinez-Camblor, C. Maldonado-Seral, B. García-García, L. Palacios-García, S. Gomez-Bernal, J. Santos-Juanes and E. Coto

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12473

      What's already known about this topic?

      • Several observational studies have assessed the association between psoriasis, psoriatic arthritis and type 2 diabetes mellitus, with inconclusive results.

      What does this study add?

      • A systematic review and meta-analysis including all observational studies up to December 2012.
      • Investigation of the influence of psoriatic arthritis and the severity of the disease on the risk of diabetes.
  6. Original articles

    1. Top of page
    2. Editor's Choice
    3. Editorial
    4. Commentary
    5. Review articles
    6. Systematic review
    7. Original articles
    8. Case report
    9. Correspondence
    10. Correspondences
    11. Book review
    12. News and Notices
    1. Cutaneous biology

      Multimodal mapping of human skin (pages 794–803)

      S. Heuke, N. Vogler, T. Meyer, D. Akimov, F. Kluschke, H.-J. Röwert-Huber, J. Lademann, B. Dietzek and J. Popp

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12427

      What's already known about this topic?

      • Multimodal nonlinear optical techniques are known to be applicable for diagnostic purposes by providing morphochemical information about biomedical samples.

      What does this study add?

      • This is the first comprehensive study to provide a map of well-known normal structures in human skin in order to facilitate further in vivo and ex vivo experiments.
    2. Clinical and laboratory investigations

      You have free access to this content
      Distribution of MC1R variants among melanoma subtypes: p.R163Q is associated with lentigo maligna melanoma in a Mediterranean population (pages 804–811)

      J.A. Puig-Butillé, C. Carrera, R. Kumar, Z. Garcia-Casado, C. Badenas, P. Aguilera, J. Malvehy, E. Nagore and S. Puig

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12418

      What's already known about this topic?

      • The MC1R gene plays a role in pigmentation synthesis and inflammatory processes, and activates the mitogen-activated protein kinase pathway.
      • MC1R variants associated with pigmentation increase the risk of developing melanoma and nonmelanoma skin cancer.
      • The p.R163Q variant, not associated with pigmentation, is associated with nonmelanoma skin cancer in Europeans.

      What does this study add?

      • The p.R163Q variant, which is not directly associated with phenotype variation, is associated for the first time with the risk of developing lentigo maligna melanoma.
    3. You have free access to this content
      E-cadherin autoantibody profile in patients with pemphigus vulgaris (pages 812–818)

      M.E.F. Oliveira, D.A. Culton, P. Prisayanh, B.F. Qaqish and L.A. Diaz

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12455

      What's already known about this topic?

      • The prevalence of anti-E-cadherin antibodies in pemphigus vulgaris (PV) is largely unknown.
      • Only patients with mucocutaneous PV (mcPV) have been reported to have anti-E-cadherin antibodies.
      • Cross-reactivity between E-cadherin and desmoglein (Dsg)1 antibodies has been suggested.

      What does this study add?

      • We showed that anti-E-cadherin antibodies are present in both mcPV and mucosal PV (mPV).
      • Moderate correlation was found between Dsg1 and E-cadherin antibodies.
      • mPV can have anti-Dsg1 antibodies, suggesting that the distinction between mPV and mcPV based on the autoantibody profile is not clear.
    4. The relationship between tumour necrosis factor (TNF)-α promoter and IL12B/IL-23R genes polymorphisms and the efficacy of anti-TNF-α therapy in psoriasis: a case–control study (pages 819–829)

      E. Gallo, T. Cabaleiro, M. Román, G. Solano-López, F. Abad-Santos, A. García-Díez and E. Daudén

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12425

      What's already known about this topic?

      • The presence of single nucleotide polymorphisms (SNPs) in the tumour necrosis factor (TNF)-α gene coding proteins has been implicated in the susceptibility and severity of other inflammatory diseases, and also with the response to anti-TNF-α drugs in these conditions.
      • SNPs of the IL12B/IL23R genes have been related to susceptibility to psoriasis.
      • The association of these and other SNPs with the response to anti-TNF-α agents, although established in other inflammatory diseases, has not been studied in psoriasis.

      What does this study add?

      • We have studied the association of certain SNPs of the TNF-α promoter and IL12B/IL23R genes with the response to anti-TNF-α in patients with psoriasis. If these results are confirmed, patients capable of mounting an effective response to anti-TNF-α treatments could be selected in order to optimize the management of patients with psoriasis.
    5. You have free access to this content
      CD133+ cell content correlates with tumour growth in melanomas from skin with chronic sun-induced damage (pages 830–837)

      I. González-Herrero, I. Romero-Camarero, J. Cañueto, E. Cardeñoso-Álvarez, E. Fernández-López, J. Pérez-Losada, I. Sánchez-García and C. Román-Curto

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12428

      What's already known about this topic?

      • Stem cells, defined by CD133 expression, have been implicated in melanoma tumour growth, but their specific role is still uncertain.

      What does this study add?

      • In the present study, we provide evidence showing, for the first time, that an increase in the content of CD133+ cells is associated with melanomas arising on skin with signs of chronic sun-induced damage and in melanomas in situ with better prognosis.
      • This study also confirms the existence of a subpopulation of CD133+CXCR4+ cancer stem cells in melanomas with invasive phenotype and poor prognosis.
    6. You have free access to this content
      Meta-analysis of the association of dermatomyositis and polymyositis with cancer (pages 838–847)

      J. Wang, G. Guo, G. Chen, B. Wu, L. Lu and L. Bao

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12564

      What's already known about this topic?

      • Necrotic skin ulcerations and pruritus, elevated erythrocyte sedimentation rate, periungual erythema and dysphagia are known risk factors for cancer in dermatomyositis (DM) and polymyositis (PM).
      • Previous studies were small in size and failed to draw definitive conclusions.

      What does this study add?

      • We report a meta-analysis of published studies.
      • Our results suggest that age, sex, cutaneous necrosis, dysphagia, arthritis and lung complications may influence the susceptibility of patients with DM or PM to cancer.
    7. You have free access to this content
      Clinical and dermoscopic characteristics of new naevi in adults: results from a cohort study (pages 848–853)

      S.A. Oliveria, S.E. Yagerman, N. Jaimes, A.I. Goodwin, S.W. Dusza, A.C. Halpern and A.A. Marghoob

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12482

      What's already known about this topic?

      • Naevogenesis is a dynamic process that occurs throughout life.
      • Adults develop comparatively fewer new naevi than children.
      • Naevi tend to maintain their dermoscopic morphology.

      What does this study add?

      • The dermoscopic morphology of new naevi in adults.
      • The rate of new naevus formation in adults.
      • Support to the theory of a dual concept of naevogenesis.
    8. Cutaneous allergy

      Nickel allergy following European Union regulation in Denmark, Germany, Italy and the U.K. (pages 854–858)

      S. Garg, J.P. Thyssen, W. Uter, A. Schnuch, J.D. Johansen, T. Menné, A. Belloni Fortina, B. Statham and D.J. Gawkrodger

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12556

      What's already known about this topic?

      • Nickel allergy affects 10–15% of women in the general population and is associated with hand eczema.
      • Previous studies have shown a decrease in nickel allergy in young women in Denmark and Germany since regulations to control nickel release were implemented.

      What does this study add?

      • Postregulation, a significant decrease in nickel allergy was seen in women with suspected dermatitis aged below 30 years in all four countries studied, and in men aged below 30 years in the U.K. and Germany, although an increase was seen in young Italian men.
      • This study of 180 390 patients shows that the EU nickel regulations are starting to reduce nickel allergy in young men and women, although allergy remains prevalent and more work needs to be done to improve compliance with the regulations.
    9. Dermatological surgery

      Effect of intense pulsed light treatment on human skin in vitro: analysis of immediate effects on dermal papillae and hair follicle stem cells (pages 859–868)

      D. Larouche, D.H. Kim, G. Ratté, C. Beaumont and L. Germain

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12477

      What's already known about this topic?

      • Clinical observations have been made following intense pulsed light (IPL) treatment.
      • Few studies analysing the overall histology of treated tissues exist, and no link has been made with stem cells or the effectiveness of the destruction of the dermal papilla.

      What does this study add?

      • This study characterizes the destruction of human hair follicles following IPL treatment, with more attention paid to epithelial stem cells and dermal papilla cells.
      • Epithelial stem cells are preserved after IPL treatment, and these cells play important roles in epidermal renewal and during wound healing.
    10. Dermatopathology

      A quantitative approach to histopathological dissection of elastin-related disorders using multiphoton microscopy (pages 869–879)

      P.L. Tong, J. Qin, C.L. Cooper, P.M. Lowe, D.F. Murrell, S. Kossard, L.G. Ng, B. Roediger, W. Weninger and N.K. Haass

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12430

      What's already known about this topic?

      • Multiphoton microscopy has been used on tissue sections and in patients to assess skin pathologies.
      • Autofluorescent structures within the skin, including elastic fibres, can be visualized using multiphoton imaging without the need for histochemical or antibody staining.

      What does this study add?

      • Development of the Dermal Elastin Morphology Index (DEMI) to enable objective three-dimensional quantification of elastic fibres.
      • Use of DEMI is demonstrated in elastin-related skin disorders.
      • DEMI can be used on tissue sections, where it correlates with histopathology, but in contrast to histopathology it allows in vivo application.
    11. Epidemiology and health services research

      Regional melanoma incidence in England, 1996–2006: reversal of north–south latitude trends among the young female population (pages 880–888)

      S.C. Wallingford, R.D. Alston, J.M. Birch and A.C. Green

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12460

      What's already known about this topic?

      • Increasing trends in melanoma incidence from north to south have been noted in England and other northern countries.
      • Melanoma predominantly affects white, affluent populations; however, neither ethnic groups nor socioeconomic status are uniformly distributed across England.

      What does this study add?

      • This study describes a striking reversal in the well-established north–south latitude trend in melanoma incidence among young women in England.
      • Incidence was high among young people in northern regions, and particularly among moderately deprived female subjects.
    12. Paediatric dermatology

      You have free access to this content
      Childhood-onset psoriasis: association with future cardiovascular and metabolic comorbidities (pages 889–895)

      E. Mahé, F. Maccari, A. Beauchet, M. Lahfa, H. Barthelemy, Z. Reguiaï, N. Beneton, E. Estève, G. Chaby, M. Ruer-Mulard, H.-G. Steiner, C. Pauwels, M. Avenel-Audran, C. Goujon-Henry, V. Descamps, E. Begon, M.-L. Sigal and for the GEM Resopso

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12441

      What's already known about this topic?

      • Psoriasis and its severity are associated with higher prevalence of cardiovascular and metabolic comorbidities in adults.
      • Childhood onset of psoriasis is not associated with obesity in adulthood.

      What does this study add?

      • Childhood onset of psoriasis is not associated with cardiovascular and metabolic comorbidities in adulthood.
      • In France, as in most countries, psoriasis is associated with high frequencies of cardiovascular and metabolic comorbidities in adults.
    13. Hair in newborns and infants: clinical and dermoscopic evaluation of 45 cases (pages 896–900)

      I. Neri, V. Piccolo, G. Cocchi, M. Starace, A. Patrizi, E. Dika and B.M. Piraccini

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12459

      What's already known on this topic?

      • To date, only a few studies have been performed on neonatal hair, mostly regarding transient neonatal hair loss.

      What does this study add?

      • Transient hair loss of the infant can be distinguished into two different types: ‘neonatal type’, rarely observed, appearing in the first 4 weeks of life with a frontal–temporal pattern, and ‘classic type’, frequently observed, appearing at 8–12 weeks of life, with a predominant occipital pattern.
    14. The European treatment of severe atopic eczema in children taskforce (TREAT) survey (pages 901–909)

      L.E. Proudfoot, A.M. Powell, S. Ayis, S. Barbarot, E. Baselga Torres, M. Deleuran, R. Fölster-Holst, C. Gelmetti, A. Hernández-Martin, M.A. Middelkamp-Hup, A.P. Oranje, K. Logan, M. Perkins, A. Patrizi, G. Rovatti, O. Schofield, P. Spuls, Å. Svensson, C. Vestergaard, C.-F. Wahlgren, J. Schmitt, C. Flohr and in collaboration with the European Dermato-Epidemiology Network (EDEN)

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12505

      What's already known about this topic?

      • There is a paucity of evidence for the use of systemic agents in children with atopic eczema refractory to conventional therapy, resulting in considerable variation in patient management.

      What does this study add?

      • The TREAT survey is the first European venture investigating current practice in the use of systemic agents in severe childhood atopic eczema.
      • The survey confirms significant variability in therapeutic approaches, although there are strong trends favouring a small number of agents, namely ciclosporin, oral corticosteroids and azathioprine.
      Corrected by:

      Erratum: Erratum

      Vol. 169, Issue 5, 1171, Article first published online: 31 OCT 2013

    15. Photobiology

      Energy-saving lamps and their impact on photosensitive and normal individuals (pages 910–915)

      L. Fenton, J. Ferguson, S. Ibbotson and H. Moseley

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12457

      What's already known about this topic?

      • Compact fluorescent lamps (CFLs) emit detectable levels of ultraviolet radiation (UVR).
      • CFLs can exacerbate chronic actinic dermatitis (CAD) with an exposure time of only 2·5 min when situated in close proximity to the skin.
      • Double-envelope CFLs emit less UVR than single-envelope CFLs.

      What does this study add?

      • Evidence that CFLs exacerbate photodermatoses, including CAD, polymorphic light eruption, solar urticaria, actinic prurigo and erythropoietic protoporphyria.
      • Double-envelope CFLs exacerbate photodermatoses to a lesser degree than single-envelope CFLs.
      • Preliminary findings that CFLs can induce erythema in healthy individuals.
      • Evidence that LEDs offer a safer alternative for photosensitive patients.
    16. Therapeutics

      Methotrexate in the treatment of pemphigus vulgaris: experience in 23 patients (pages 916–921)

      K.D. Tran, J.E. Wolverton and N.A. Soter

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12474

      What's already known about this topic?

      • Systemic glucocorticoids have long been the standard first-line treatment in pemphigus vulgaris, but are associated with considerable morbidity.
      • The optimal adjuvant systemic therapy for pemphigus vulgaris has yet to be determined.

      What does this study add?

      • In 23 patients with pemphigus vulgaris treated with methotrexate at our centre, 91% were able to reduce their dosage of prednisone, with 70% able to discontinue prednisone completely after a median interval of 18 months.
      • Methotrexate is a useful, well-tolerated, and possibly underutilized drug in the treatment of pemphigus vulgaris. It successfully controls blistering as a systemic monotherapy in the majority of patients.
    17. Concise communications

      Detection of skin cancer margins in Mohs excisions with high-speed strip mosaicing confocal microscopy: a feasibility study (pages 922–926)

      B. Larson, S. Abeytunge, E. Seltzer, M. Rajadhyaksha and K. Nehal

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12444

      What's already known about this topic?

      • Fluorescence confocal mosaicing microscopy is an emerging technology for imaging of nuclear and morphological detail and assessing tumour margins directly in fresh Mohs excisions, without the need for frozen section processing.
      • Basal cell carcinoma margins have been detected with a sensitivity of 96·6% and a specificity of 89·2%.

      What does this study add?

      • A new and faster approach called strip mosaicing confocal microscopy has been developed, towards potentially routine implementation at the bedside.
      • Preliminary assessment demonstrates both sensitivity and specificity of 94% for detecting skin cancer margins.
    18. Evidence for a polygenic contribution to androgenetic alopecia (pages 927–930)

      S. Heilmann, F.F. Brockschmidt, A.M. Hillmer, S. Hanneken, S. Eigelshoven, K.U. Ludwig, C. Herold, E. Mangold, T. Becker, R. Kruse, M. Knapp and M.M. Nöthen

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12443

      What's already known about this topic?

      • Androgenetic alopecia is a highly heritable trait and the most common form of hair loss in humans. Eight genetic susceptibility loci have been linked with male pattern baldness.

      What does this study add?

      • This study provides molecular genetic evidence that a polygenic component contributes to the individual risk of developing androgenetic alopecia.
    19. Treatment of scabies with oral ivermectin in 15 infants: a retrospective study on tolerance and efficacy (pages 931–933)

      C. Bécourt, C. Marguet, X. Balguerie and P. Joly

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12454

      What's already known about this topic?

      • The use of oral ivermectin is off label in infants weighing < 15 kg.
      • Up to now, no series has specifically reported on the use of oral ivermectin in infants.

      What does this study add?

      • Two doses of oral ivermectin healed 80% of infants with scabies who had previously failed to respond to topical treatments.
      • Only two mild and transient side-effects were observed, suggesting that ivermectin could be used for the treatment of recalcitrant scabies in infants.
  7. Case report

    1. Top of page
    2. Editor's Choice
    3. Editorial
    4. Commentary
    5. Review articles
    6. Systematic review
    7. Original articles
    8. Case report
    9. Correspondence
    10. Correspondences
    11. Book review
    12. News and Notices
    1. Acute kidney injury in patients with severe rash on vemurafenib treatment for metastatic melanomas (pages 934–938)

      E. Regnier-Rosencher, H. Lazareth, L. Gressier, M.F. Avril, E. Thervet and N. Dupin

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12555

      What's already known about this topic?

      • Vemurafenib, a selective BRAF (v-raf murine sarcoma viral oncogene homologue B1) inhibitor is used to treat metastatic melanoma in patients with BRAF mutations.
      • It has significant dermatological adverse effects, but acute kidney injury (AKI) has never before been reported in treated patients.

      What does this study add?

      • We report a cluster of four cases of AKI associated with severe grade 3 (Common Terminology Criteria for Adverse Events) cutaneous drug reactions related to vemurafenib. Vemurafenib was reintroduced at a lower dose, without a relapse of the rash, but renal function deteriorated again. This association with a rapid major or complete response raises numerous questions.
  8. Correspondence

    1. Top of page
    2. Editor's Choice
    3. Editorial
    4. Commentary
    5. Review articles
    6. Systematic review
    7. Original articles
    8. Case report
    9. Correspondence
    10. Correspondences
    11. Book review
    12. News and Notices
    1. Frontal fibrosing alopecia: a clinical review of 20 black patients from South Africa (pages 939–941)

      N.C. Dlova, H.F. Jordaan, A. Skenjane, N. Khoza and A. Tosti

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12424

    2. Gene–gene interactions between HLA-C, ERAP1, TNFAIP3 and TRAF3IP2 and the risk of psoriasis in the Chinese Han population (pages 941–943)

      X.-Y. Yin, R. Zhang, H. Cheng, Q. Pan, C.-B. Shen, X. Fan, Z.-X. Wang, L.-D. Sun, S. Yang and X.-J. Zhang

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12442

    3. Familial pyoderma gangrenosum in association with common variable immunodeficiency (pages 944–946)

      L. Boussofara, R. Gammoudi, N. Ghariani, A. Aounallah, B. Sriha, M. Denguezli, C. Belajouza and R. Nouira

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12431

    4. Use of high-definition optical coherent tomography (HD-OCT) for imaging of melanoma (pages 950–952)

      A. Picard, K. Tsilika, E. Long-Mira, P. Hofman, T. Passeron, J.-P. Lacour and P. Bahadoran

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12433

    5. Novel management of harlequin syndrome with stellate ganglion block (pages 954–956)

      H. Reddy, S. Fatah, A. Gulve and A.J. Carmichael

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12561

  9. Correspondences

    1. Top of page
    2. Editor's Choice
    3. Editorial
    4. Commentary
    5. Review articles
    6. Systematic review
    7. Original articles
    8. Case report
    9. Correspondence
    10. Correspondences
    11. Book review
    12. News and Notices
  10. Book review

    1. Top of page
    2. Editor's Choice
    3. Editorial
    4. Commentary
    5. Review articles
    6. Systematic review
    7. Original articles
    8. Case report
    9. Correspondence
    10. Correspondences
    11. Book review
    12. News and Notices
    1. Practical Dermatopathology (page 958)

      J.C. Cardoso

      Article first published online: 10 OCT 2013 | DOI: 10.1111/bjd.12601

  11. News and Notices

    1. Top of page
    2. Editor's Choice
    3. Editorial
    4. Commentary
    5. Review articles
    6. Systematic review
    7. Original articles
    8. Case report
    9. Correspondence
    10. Correspondences
    11. Book review
    12. News and Notices

SEARCH

SEARCH BY CITATION